Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
9 studies found for:    Open Studies | "Rhinitis, Allergic, Perennial"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Rhinitis, Allergic, Perennial"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Effectivness and Safety of Acupuncture Combined With Moxibustion for Allergic Rhinitis
Condition: Rhinitis, Allergic, Perennial
Interventions: Device: acupuncture combined moxibustion;   Drug: Loratadine
2 Recruiting Clinical Trial to Evaluate the Efficacy and Safety of CKD-342
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: CKD-342;   Drug: Mometasone furoate;   Drug: Levocabastine HCL
3 Not yet recruiting Clinical Study, Non Inferiority Between Noex® 50µg Versus Busonid® 50µg in Treatment of Allergic Rhinitis
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Budesonid 50mcg (Noex);   Drug: Budesonid 50mcg (Busonid)
4 Not yet recruiting Clinical Study, Non Inferiority Between Noex® 32µg Versus Budecort Aqua® 32µg in Treatment of Alergic Rhinitis
Condition: Rhinitis, Allergic, Perennial
Intervention: Drug: Budesonide
5 Recruiting Repeated Dosing Clinical Trial of HL151
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: HL151;   Drug: TALION tab.
6 Not yet recruiting Effectiveness of Qufeng Shengshi Fang on Treatment of Allergic Rhinitis.
Condition: Rhinitis, Allergic, Perennial
Interventions: Drug: Qufeng Shengshi Fang and Loratadine;   Drug: Loratadine
7 Recruiting A Study to Compare the Efficacy and Safety of Fluticasone Furoate Nasal Sprays (FFNS) 55 Microgram (mcg) and 110 mcg in Chinese Pediatric Subjects With Allergic Rhinitis (AR)
Condition: Rhinitis, Allergic, Perennial and Seasonal
Interventions: Drug: FFNS;   Other: Placebo
8 Recruiting Efficacy and Safety of STG320 Sublingual Tablets of House Dust Mite (HDM) Allergen Extracts in Adults and Adolescents With HDM-associated Allergic Rhinitis
Conditions: Rhinitis, Allergic, Perennial;   House Dust Mite Allergy
Interventions: Biological: 300 IR;   Biological: Placebo
9 Not yet recruiting Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust Mites
Condition: Allergic Rhinitis
Interventions: Biological: modified allergen extract of house dust mites;   Biological: placebo

Study has passed its completion date and status has not been verified in more than two years.